Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1316
Selected: 0
NCT IDTitle
NCT00512850Folic Acid in Preventing Colorectal Polyps in Patients With Previous Colorectal Polyps
NCT07147023Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication
NCT03089125Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
NCT00593008Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer
NCT01534078Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma
NCT02903368Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
NCT02279394E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
NCT03139331PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
NCT02827773Improving Medication Adherence: A Study With Talking Pill Bottles
NCT03137537Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
NCT02919683Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity
NCT01858688A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
NCT00139269Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT02909777Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
NCT00153907Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
NCT00264602Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
NCT06313437Revumenib in Combination With 7+3 + Midostaurin in AML
NCT02287519Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention
NCT06472869Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening
NCT01415492Multiple Risk Behavior Intervention in Health Care Settings
NCT03660228Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS
NCT03410875A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
NCT03236428Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
NCT00804336Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
NCT03070145Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy
NCT02340676A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD
NCT07624513Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
NCT03279055Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors
NCT07551635SMARCA4/2 Inhibitor for POU2F3-Positive SCLC
NCT05356117Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
NCT06736548Sleep Treatment Education Program for Cancer Survivors: STEP-Together
NCT00139243Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
NCT00903968Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma
NCT00136474Amifostine for Head and Neck Irradiation in Lymphoma
NCT04724018Sacituzumab Govitecan Plus EV in Metastatic UC
NCT01629615A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer
NCT02698891Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer
NCT03239145Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
NCT07123090A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
NCT02028988Enzalutamide + External Beam Rt For Prostate
NCT05190705Loncastuximab Tesirine in WM
NCT03417739A Phase II Study of BVD-523 in Metastatic Uveal Melanoma
NCT00856180Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies
NCT03436654Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
NCT01068769Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
NCT04045470A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
NCT01004172Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
NCT01783587Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer
NCT03225716A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia
NCT07482384Supporting Health Including Endocrine Treatment for Long Duration